Proteo Biotech AG
- ISIN US74369R1005
- Country Deutschland
Company profile
Proteo Inc., together with its subsidiary, is engaged in the development of pharmaceuticals based on the body’s own tools and weapons to fight inflammatory diseases. Proteo is a clinical stage drug development company and intends to develop, promote and market pharmaceuticals and other biotech products. The Company’s focus is on the development of anti-inflammatory treatments for rare diseases with significant unmet needs.